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Abstract
Purpose The aim of this retrospective cohort study was to
evaluate the rate of complications in relation to the extent of
surgery and some of its consequences.
Methods Between 1972 and 2010, a total of 5,277 consec-
utive thyroid gland surgeries with 7,383 nerves at risk were
performed at our teaching institution. Data of all patients
undergoing thyroidectomy were collected prospectively. A
total of 2,867 subtotal resections (first study period from
1972 to 1990) were compared with 2,410 extended thyroid
resections involving at least a hemithyroidectomy (second
period from 1991 to 2010).
Results The incidence of permanent recurrent laryngeal
nerve palsy in primary operations was significantly higher
in the first period compared to the second period (3.6 vs.
0.9 %; p<0.001). Permanent hypoparathyroidism decreased
from 3.2 % in the first period to 0.8 % in the second period
(p<0.001). The incidence of recurrent goiter surgery de-
creased from 11.1 % in the first period to 8.1 % in the
second period (p<0.001). No significant difference was
found in permanent recurrent laryngeal nerve palsy in re-
current disease between the two periods. The socioeconomic
benefits of an extended thyroid resection in our patient
population are 360 preventable operations, 90 preventable
permanent recurrent laryngeal nerve palsies, and 58 prevent-
able cancers. Furthermore, 37 preventable radioiodine abla-
tions and 15 preventable deaths were associated with more
radical thyroid resection.
Conclusion Improvements in surgical technique and change
in surgical strategy significantly decreased the prevalence of
recurrent laryngeal nerve palsy, hypoparathyroidism, and
recurrent disease as well as reduced public health costs
associated with recurrent goiter.




Subtotal thyroidectomy or nodal enucleation has become the
“gold standard” treatment for multinodular benign goiter
since Theodor Kocher published his experiences in thyroid
surgery over 100 years ago [1, 2]. In addition to establishing
these surgical principles, Theodor Kocher researched the
etiology of multinodular goiter disease and introduced the
addition of iodine to table salt in Switzerland in 1922. In
spite of sufficient dietary iodine intake in the present day,
multinodular goiter remains an endemic disease in Switzer-
land [3]. Further research and understanding of the molec-
ular growth mechanism in goitrogenesis [4–6] and an
inacceptable high recurrence rate associated with subtotal
thyroidectomy led endocrine surgeons to adopt a more ex-
tended surgical resection for benign multinodular goiter
disease [7–11]. Previous studies showed that total thyroid
resection is a safe procedure. However, these studies includ-
ed mostly small numbers of patients or a short observation
period of less than 20 years [12–14].
Public health costs are primarily reflected in the costs of
operative morbidity and redo surgery. However, cost analy-
sis in thyroid surgery is mainly focused on length of hospital
stay and surgical devices, among other issues [15, 16].
There is no study investigating the socioeconomic benefits
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of a more radical thyroid resection. The aim of this retro-
spective cohort study was to evaluate morbidity rate and
socioeconomic benefits in relation to the extent of surgery
with a large prospective single institutional cohort database
spanning over 39 years.
Material and methods
Patients
Between 1972 and 2010, a total of 5,277 consecutive
thyroid gland surgeries with 7,383 nerves at risk were
performed at our teaching institution with a special interest
in endocrine surgery. Data of all patients undergoing thy-
roidectomy were collected prospectively in an electronic
database and analyzed retrospectively. The primary aim of
this database was to provide data for quality control of
thyroid surgery at our institution. Questionnaires were
completed up to 1 year after the operation and contained
information about patients’ demographic parameters, oper-
ative procedures, intraoperative complications, and local
and general postoperative complications. Overall loss to
follow-up was 1 %.
In the present analysis, two study periods were compared.
In the first study period from 1972 to 1990, patients under-
went subtotal resections. In the second study period from
1991 to 2010, extended resections involving at least hemi-
thyroidectomy or total thyroidectomy were performed.
Methods
According to Kocher’s principles [1, 2], during the first
study period from 1972 to 1990, a total of 2,867 patients
underwent subtotal thyroidectomy (leaving at least 4–8 ml
of thyroid tissue in place) or nodal enucleations of thyroid
nodules in order to avoid thyroid hormone substitution.
In the second study period from 1991 to 2010, a total of
2,410 patients were included. A hemithyroidectomy was
performed in patients with strictly unilateral thyroid disease.
A total thyroidectomy was performed in cases of cancer or
when nodules were present in both thyroid lobes. In cases of
malignancy, lymphadenectomy was performed accordingly.
In our teaching hospital, the operations were performed
by residents following a strict protocol; however, a staff
surgeon was present in all operations in both study periods.
Standardized visualization of the recurrent laryngeal nerves
and the parathyroid glands was performed routinely in all
operations in the second study period from 1991 to 2010.
Furthermore, neuromonitoring was used routinely in the
second study period since 2003 [17]. Removed tissue was
submitted for intraoperative frozen section analysis, and
histological analyses were performed in all patients.
Persistent recurrent laryngeal nerve palsy was defined as
nerve palsy lasting more than 12 months after the operation.
Vocal cord function was documented pre- and postopera-
tively by laryngoscopy in all patients. If postoperatively
recurrent laryngeal nerve palsy was observed, patients un-
derwent phoniatric consultations and logotherapy and were
followed for 1 year.
Persistent hypoparathyroidism was defined as hypocal-
cemia lasting more than 12 months after surgery. Transplan-
tation of parathyroid glands into the sternocleidomastoid
muscle was performed if a parathyroid gland was devascu-
larized during the operation. General practitioners were
contacted by phone 1 year after the operation if a prescrip-
tion of vitamin D and calcium was given at discharge.
Model of cost analysis
Operative and in-hospital costs for thyroidectomy were
assessed on the basis of the Swiss All Patient Diagnosis-
Related Groups (APDRG) 2010 (total costs, 8,190.20 EUR).
The median salary of an inhabitant per month in Switzerland
in 2008 was 4,512.93 EUR referred to the federal office for
statistics in Switzerland. With a median lack of work after
thyroidectomy of 10 days, a loss of salary of 1,504.31 EUR
per patient was calculated. Median cost of 1,278.78 EUR per
patient for recurrent laryngeal nerve palsy therapy including at
least three phoniatric consultations and 12 logotherapy ses-
sions was calculated. Costs of radioiodine ablation therapy
were also based on the Swiss APDRG and resulted in
5,010.38 EUR per case. All results are presented in Euros
(€) using values for 2011 (1 CHF00.775 EUR).
Outcome parameters
The primary outcome parameter of this study was permanent
recurrent laryngeal nerve palsy in relation to the extent of
surgery. Secondary outcome measures were permanent hypo-
parathyroidism, recurrence rate, and total cost of redo surgery.
Statistical analysis
Student’s t test was performed to determine the significance
between continuous variables. Categorical variables were
compared using Fisher’s exact test. One-way ANOVA was
used to analyze linear regression models. P values were
two-sided, and p<0.05 was considered statistically signifi-
cant (NCSS 2007 for Windows; NCSS, Kaysville, UT).
Results
A total of 5,277 patients with 7,383 nerves at risk underwent
thyroid gland surgery between 1972 and 2010 at our
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institution and were included in this study. Subtotal resec-
tions were performed in 2,867 cases (first study period), and
extended thyroid resections involving at least hemithyroi-
dectomy were performed in 2,410 cases (second study peri-
od). In the second study period, 925 patients (38.4 %)
underwent hemithyroidectomy, and 1,485 (61.6 %) patients
underwent total thyroidectomy. Demographic parameters
including age and sex were not significantly different be-
tween groups. Table 1 reports indications for primary and
redo operation. A total of 196 patients who received redo
surgery in the second study period had had primary opera-
tion during the first period or subtotal resection elsewhere.
Table 2 shows long-term outcomes after thyroid surgery
between the two study groups. The incidence of permanent
recurrent laryngeal nerve palsy with primary operations was
significantly higher in the first period compared to the
second period (3.6 vs. 0.9 %; p<0.001). Bilateral nerve
palsy was significantly higher in the first period compared
to the second period (2.3 vs. 0.13 %; p<0.001). Permanent
hypoparathyroidism during primary surgery decreased
from 3.2 % in the first period to 0.8 % in the second
period (p<0.001). Permanent RLN palsy was found in
the time period from 1991–2002 in 0.94 % (20/2,128
nerves at risk) and from 2003–2010 in 0.88 % (13/1,485
nerves at risk; p00.723). Permanent hypoparathyroidism
in the time period from 1991–2002 was found in 0.6 %
(9/1,482) and from 2003–2010 in 1.1 % (10/928 patients;
p00.239).
The incidence of recurrent goiter surgery in the first
period was 11.1 % and decreased to 8.1 % in the second
period (p<0.001). Linear regression analysis showed a
significant decrease over the whole study period (p<0.001;
Fig. 1).
A total of 515 redo operations for recurrent diseases were
performed between 1972 and 2010. Seventy percent of
recurrent diseases were ipsilateral. This resulted in 360
preventable ipsilateral redo operations, 90 preventable re-
current laryngeal nerve palsies, and 58 preventable malig-
nant diseases with the extended type of resection.
Furthermore, 37 preventable radioiodine ablation therapies
(radioiodine ablation therapy was necessary in 64 % of these
cases [18]) and 15 additionally preventable deaths during
our study period of 39 years were associated with the
extended technique in the present study population. A mod-
el of cost analysis including only objective factors is repre-
sented in Table 3.
Discussion
A significant reduction in permanent recurrent laryngeal
nerve palsy and hypoparathyroidism in primary operations
was found with extended thyroid resection. The incidence of
recurrent goiter surgery was also significantly reduced with
this approach. Public health costs are tremendously affected
with recurrent diseases.
The prevailing thought until at least 1980s was that hemi-
thyroidectomy or total thyroidectomy was a risky operation.
The present results emphasize our previously reported findings
[10], now over a period of 39 years, namely that an extended
thyroid resection is associated with a significantly reduced rate
of permanent nerve palsy and hypoparathyroidism compared to
Table 1 Demographic parame-
ters, indication for primary and
redo surgery, and surgical
technique
Values in parentheses are
percentages
bValues are median (range)
aFisher’s exact test unless indi-
cated otherwise
cStudent’s t test
First study period Second study period p valuea
1972–1990 1991–2010
n02,867 n02,410
Age (years)b 52 (15–75) 53 (15–83) 0.901c
Sex (male/female) (20.3/79.7) (19.7/80.3) 0.907
Primary surgery
Benign nodular goiter 1,631 (64.0) 1,400 (63.2) 0.587
Hyperthyroidism 522 (20.5) 460 (20.8) 0.123
Malignancy 395 (15.5) 354 (16.0) 0.661
Redo surgery
Benign nodular goiter 249 (78.1) 151 (77.0) 0.828
Hyperthyroidism 16 (5.0) 16 (8.2) 0.188
Malignancy 54 (16.9) 29 (14.8) 0.540
Typ of resection
Subtotal lobe resection 1,673 –
Bilateral subtotal resection 621 –
Hemithyroidectomy 573 925
Total thyroidectomy – 1,485
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subtotal resection. The risk of morbidity was significantly
lower in the second study period due to (a) change in general
surgical strategy, meaning hemithyroidectomy in all eligible
patients with unilateral benign thyroid diseases or total thyroid-
ectomy in bilateral benign disease, and (b) change in surgical
technique with obligatory visualization of the recurrent laryn-
geal nerves and the parathyroid glands. Two meta-analyses
showed no difference in the occurrence of permanent compli-
cations between subtotal and total thyroidectomy [7, 9]. The
significantly lower morbidity rate with themore radical surgical
approach in the present study reflects the experience in endo-
crine surgery at our institution, with over 5,000 thyroid oper-
ations performed over a 39-year period.
Subtotal thyroidectomy is associated with recurrent dis-
eases in 7–50 % [11, 14, 19–21]. However, long-term
follow-up is necessary to evaluate correct recurrence rate
[9]. In the present study, change in surgical technique led to
a significant reduction in the recurrence rate and is a conse-
quence of the more radical thyroid resection in the second
study period. There were no differences in permanent recur-
rent laryngeal nerve palsy in recurrent disease between the
two periods. However, reoperation is associated with an
increased morbidity rate due to postoperative adhesions
compared to primary surgery. This indicates that surgical
strategy in the primary operation represents a cornerstone in
preventing redo surgery with its associated high morbidity
rate. Furthermore, the threat of bilateral recurrent nerve
palsy demanding tracheostomy is probably preventable with
the more radical surgical approach.
Recurrent disease is not only associated with a high
morbidity rate during redo surgery but also with socioeco-
nomic drawbacks and increased costs. In the present cost
analysis model, only objective factors were taken into ac-
count. Disadvantages of subtotal resection such as recurrent
diseases and high mortality rate were associated with overall
costs of 3,790,497.95 EUR. These expenses are equalizing
with 99,749.95 EUR savings per year or with hospital costs
of 12 thyroidectomies per year over the whole study period
of 39 years, respectively. The findings of Crevenna et al.
indicated that patients with nonmetastatic well-differentiated
thyroid cancer showed significant deficits in health-related
quality of life [22]. Furthermore, the adverse effects of 58
preventable cancers in quality of life were challenging to
express in direct costs but should be considered in evaluat-
ing the above-mentioned costs.
Limitations of the study include lack of randomization.
However, long follow-up period and documentation of com-
plication rate in a large series of patients are of potential
interest. Intraoperative nerve monitoring was started in
2003. Variation of technical equipment and technique of
intraoperative nerve monitoring cannot be excluded over a
long time period from 2003 to 2010. Only patients referred
to our clinic were included in the analysis of recurrent
disease. However, as a tertiary center specializing in endo-
crine surgery, the probability that patients with recurrent
Table 2 Outcome parameters
Values in parentheses are
percentages
aFisher’s exact test
First study period Second study period p valuea
1972–1990 1991–2010
n02,867 n02,410
Hypoparathyroidism 93 (3.2) 19 (0.8) <0.001
Primary surgery 2,548 2,214
Nerves at risk 2,925 3,613
Recurrent nerve palsy 105 (3.6) 33 (0.9) <0.001
Redo surgery 319 196
Nerves at risk 563 282
Recurrent nerve palsy 30 (5.3) 10 (3.5) 0.304
Fig. 1 Redo surgery for recurrent disease. Linear regression analysis
shows a significant decrease over the whole study period (p<0.001)
Table 3 Model of preventable costs
Number Costs Total costs
Thyroidectomy 360 8,190.20 EUR 2,948,472.00 EUR
Loss of salary 360 1,504.31 EUR 541,551.60 EUR
Recurrent nerve palsies 90 1,278.78 EUR 115,090.29 EUR
Radioiodine ablation 37 5,010.38 EUR 185,384.06 EUR
Total preventable costs 3,790,497.95 EUR
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diseases were treated elsewhere is very low. Cost analysis
was performed retrospectively on the basis of the current pay
scale, and only objective, well-reproducible factors were in-
cluded, whereas cost inflations were not taken into account.
Conclusion
In conclusion, improvements in surgical technique and
change in surgical strategy significantly decreased the prev-
alence of recurrent laryngeal nerve palsy, hypoparathyroid-
ism, and recurrent disease as well as reduced public health
costs associated with recurrent goiter. Further studies pro-
spectively investigating costs of socioeconomic factors in
thyroid surgery are necessary and will probably be higher
than the present calculations.
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